Table 2.
Weighted prevalence rates for hypertension, type 2 diabetes, and dyslipidemia by metal metabolite.
| Urinary barium | Urinary cesium | ||||
|---|---|---|---|---|---|
| Low concentration | High concentration | Low concentration | High concentration | ||
| Hypertension, % | 36.4 (0.6) | 36.1 (1.2) | 37.0 (0.6) | 33.8 (1.1)∗ | |
| Type 2 diabetes, % | 10.1 (0.4) | 8.2 (0.6)∗ | 10.1 (0.4) | 8.3 (0.7)∗ | |
| Dyslipidemia, % | 52.6 (0.7) | 57.2 (1.3)∗ | 53.3 (0.7) | 54.7 (1.3) | |
|
| |||||
| Urinary antimony | Urinary uranium | ||||
| Low concentration | Moderate concentration | High concentration | Low concentration | High concentration | |
| Hypertension, % | 36.5 (0.9) | 36.6 (1.0) | 31.2 (1.3) | 35.5 (0.7) | 35.4 (1.4) |
| Type 2 diabetes, % | 9.5 (0.5) | 10.3 (0.5) | 8.8 (0.7) | 9.5 (0.4) | 11.6 (0.9)∗ |
| Dyslipidemia, % | 50.1 (0.9) | 55.6 (1.0)∗ | 57.4 (1.2)∗ | 51.9 (0.7) | 55.9 (1.5) ∗ |
|
| |||||
| Blood cadmium | Urinary cadmium | ||||
| Low concentration | High concentration | Low concentration | High concentration | ||
| Hypertension, % | 36.7 (0.5) | 36.8 (0.8) | 34.8 (0.6) | 44.0 (1.3)∗ | |
| Type 2 diabetes, % | 10.1 (0.3) | 9.4 (0.4) | 9.1 (0.3) | 12.9 (0.8)∗ | |
| Dyslipidemia, % | 52.2 (0.5) | 58.2 (0.9) | 52.2 (0.7) | 61.1 (1.3)∗ | |
|
| |||||
| Blood lead | Urinary lead | ||||
| Low concentration | High concentration | Low concentration | High concentration | ||
| Hypertension, % | 34.3 (0.5) | 49.4 (1.0)∗ | 35.4 (0.6) | 41.2 (1.4)∗ | |
| Type 2 diabetes, % | 9.9 (0.3) | 10.2 (0.5) | 9.7 (0.4) | 9.7 (0.7) | |
| Dyslipidemia, % | 53.0 (0.5) | 55.3 (0.9)∗ | 52.6 (0.7) | 58.9 (1.3)∗ | |
Weighted prevalence (SE) reported. ∗P ≤ 0.05, different from low-concentration group.